![Martin Mauritius Ebner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Martin Mauritius Ebner first degree
Entity | Entity type | Industry | |
---|---|---|---|
LamKap Bio beta AG
![]() LamKap Bio beta AG BiotechnologyHealth Technology LamKap Bio beta AG specializes in research and development. It also focuses on licensing and marketing of medical therapies, in particular antibody-based therapies against cancer and diseases of the immune system. The company was founded on December 12, 2017 and is headquartered in Pfäffikon, Switzerland.
1
| Private Company | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Martin Mauritius Ebner via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
AB2 Bio SA
![]() AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Discoveric Bio Gamma AG | Chairman | ||
discoveric bio beta AG | Chairman | ||
discoveric bio alpha AG | Chairman | ||
discoveric marina AG | Chairman | ||
Lamkap Bio Gamma AG | Chairman | ||
Lamkap Bio Alpha AG | Chairman | ||
Discoveric AG | Chairman | ||
Entsia International AG | Chairman | ||
Berta Holding AG
![]() Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Biotechnology | Chairman | |
NOVIMMUNE SA | Medical/Nursing Services | Chairman | |
International Institute for Management Development | College/University | Director/Board Member | |
EngMab SARL
![]() EngMab SARL Pharmaceuticals: MajorHealth Technology EngMab SARL operates as a biotechnology company. It focuses on cancer immunotherapy and hematological malignancies and solid tumors. The company was founded by Klaus Strein in 2013 and is headquartered in Pfäffikon, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO | |
Pharmaq Holding AS
![]() Pharmaq Holding AS Financial ConglomeratesFinance Pharmaq Holding AS invests in shares, obligations, real properties, and other participations. The company was founded on February 22, 2013 and is headquartered in Overhalla, Norway. | Financial Conglomerates | Director/Board Member | |
Roche Holdings, Inc.
![]() Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member | |
Roche Diagnostics GmbH
![]() Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Director of Finance/CFO | |
BB BIOTECH AG | Financial Conglomerates | Chairman | |
CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO | |
Roche Ventures
![]() Roche Ventures Investment ManagersFinance Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002. | Investment Managers | Director of Finance/CFO | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
Diethelm Keller Holding AG
![]() Diethelm Keller Holding AG Miscellaneous Commercial ServicesCommercial Services Diethelm Keller Holding Ltd. holding company with interest in providing brand management, marketing, logistics and travel services. The firm brands include EDAK, Koenig, Turmix, Zyliss, Wetrok, Delta and Gloster. The company is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Corange Ltd.
![]() Corange Ltd. Pharmaceuticals: GenericHealth Technology Part of Roche Holding AG, Corange Ltd. is a Bermudian company that manufactures orthopedic and diagnostics equipment. The company is based in Hamilton, Bermuda. Corange was acquired by Roche Holding AG on May 01, 1997 for $10,930.22 million. | Pharmaceuticals: Generic | Director of Finance/CFO | |
Discoveric Marketplace AG | Chairman |
Statistics
International
Switzerland | 22 |
United States | 3 |
Norway | 2 |
Germany | 2 |
Japan | 2 |
Sectoral
Health Technology | 9 |
Finance | 5 |
Consumer Services | 3 |
Commercial Services | 3 |
Health Services | 2 |
Operational
Chairman | 13 |
Director/Board Member | 10 |
Director of Finance/CFO | 5 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Erich Hunziker | 28 |
- Stock Market
- Insiders
- Martin Mauritius Ebner
- Company connections